Clinical Trial Update: To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of dual antithrombotic regimens (rivaroxaban plus aspirin and clopidogrel plus aspirin) in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Sarmad Zahoor | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN